lack
despit
frequenc
rv
detect
exist
data
predominantli
base
adult
studi
conflict
whether
rv
detect
prehct
period
result
wors
outcom
pathogen
detect
often
lead
hct
delay
due
risk
urti
progress
lrti
respiratori
failur
death
optim
length
hct
delay
unknown
continu
detect
rv
pcr
may
repres
prolong
viral
shed
thu
prehct
rv
detect
may
lead
unnecessari
delay
hct
result
wors
outcom
oncolog
relaps
rpp
multiplex
pcr
assay
becam
avail
children
merci
kansa
citi
decemb
test
offer
part
prehct
evalu
aim
determin
preval
rv
identifi
preallogen
hct
children
compar
outcom
children
rv
detect
children
without
viral
detect
determin
associ
clinic
symptom
lack
thereof
patient
outcom
conduct
retrospect
studi
subject
undergo
allogen
hct
januari
februari
children
merci
kansa
citi
rpp
test
within
day
prior
hct
midturbin
nasal
aspir
specimen
obtain
discret
hct
physician
either
diagnost
evalu
symptomat
patient
prehct
surveil
asymptomat
patient
test
clinic
purpos
specimen
obtain
januari
also
offer
laboratori
time
howev
specimen
exclud
studi
due
poor
sensit
rhinoviru
prehct
repeat
test
prior
hct
obtain
discret
treat
physician
determin
whether
viral
detect
ongo
posthct
repeat
test
obtain
discret
treat
physician
due
presenc
clinic
symptom
formal
polici
hospitalwid
isol
precaut
exist
regard
manag
patient
posit
test
result
demograph
clinic
symptom
virolog
test
laboratori
valu
imag
outcom
manual
abstract
electron
medic
record
enter
redcap
databas
subject
defin
asymptomat
ie
provid
document
sign
symptom
respiratori
ill
histori
physic
examin
symptomat
ie
provid
document
histor
symptom
physic
examin
sign
consist
respiratori
ill
symptomat
subject
includ
urti
ie
provid
document
parent
report
respiratori
symptom
neg
pulmonari
imag
includ
chest
radiograph
chest
comput
tomographi
lrti
ie
provid
document
parent
report
respiratori
symptom
abnorm
pulmonari
imag
patient
schedul
hct
date
time
specimen
obtain
hct
delay
determin
whether
date
chang
whether
due
specimen
result
patient
sole
rv
detect
viru
neg
specimen
n
includ
analysi
sinc
aim
evalu
outcom
children
rv
rvposit
viru
neg
children
significantli
differ
term
age
gender
insur
statu
rvposit
children
significantli
less
like
white
tabl
major
children
immunodefici
rv
detect
differ
underli
diseas
signific
overal
hctrelat
variabl
specimen
type
test
platform
differ
group
specimen
obtain
median
day
viru
neg
day
rvposit
prior
hct
antimicrobi
gvhd
prophylact
regimen
significantli
differ
two
group
alter
base
detect
rv
specimen
includ
final
analysi
specimen
obtain
asymptomat
children
tabl
major
viru
neg
n
rvposit
n
patient
asymptomat
symptomat
patient
pulmonari
imag
use
differenti
upper
lrti
one
viru
neg
seven
rvposit
patient
urti
five
viru
neg
two
rvposit
patient
lrti
signific
differ
type
symptom
note
viru
neg
rvposit
patient
figur
one
patient
child
rv
lrti
underw
hct
delay
day
viru
neg
rvposit
group
similar
rate
ventil
support
length
stay
initi
hospit
within
first
day
posthct
differ
note
day
aliv
hospit
readmiss
rate
gvhd
relaps
rate
mortal
tabl
overal
minor
children
undergo
hct
viral
cultur
exclud
due
poor
sensit
rv
singl
site
studi
find
may
generaliz
children
hospit
differ
underli
condit
chemotherapi
protocol
virus
sequenc
subsequ
detect
could
repres
acquisit
new
strain
rather
continu
shed
howev
high
rate
rv
detect
subsequ
specimen
highlight
wait
rv
longer
detect
may
feasibl
option
children
urgent
need
hct
addit
rv
indistinguish
enterovirus
commerci
assay
howev
previou
data
suggest
rv
present
data
relat
outcom
children
rv
larger
studi
need
determin
optim
manag
patient
none
author
deni
conflict
interest
